Reference
Stevanovic J, et al. Economic Evaluation of Primary Prevention of Cardiovascular Diseases in Mild Hypertension: A Scenario Analysis for the Netherlands. Clinical Therapeutics : 14 Feb 2014. Available from: URL: http://dx.doi.org/10.1016/j.clinthera.2014.01.008
Additional information
* The study was supported by Sanofi, Netherlands.
Rights and permissions
About this article
Cite this article
Is SBP reduction in mild hypertension cost effective?. PharmacoEcon Outcomes News 698, 6 (2014). https://doi.org/10.1007/s40274-014-1102-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1102-x